Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Полное описание

Библиографические подробности

Главные авторы:	Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Формат:	Artigo
Язык:	Inglês
Опубликовано:	The Journal of Infection in Developing Countries 2024-05-01
Серии:	Journal of Infection in Developing Countries
Предметы:	Chronic HCV infection hepatocellular carcinoma liver cirrhosis direct-acting antiviral agents
Online-ссылка:	https://jidc.org/index.php/journal/article/view/18410
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!